Stockscreener 앱 받기
35.40
2.93%
-1.07
시장 영업 전:
34.45
-0.95
-2.68%
전일 마감가:
$36.47
열려 있는:
$36.6
하루 거래량:
12,334
Relative Volume:
0.41
시가총액:
$309.44M
수익:
$64.99M
순이익/손실:
$-4.30M
주가수익비율:
-68.08
EPS:
-0.52
순현금흐름:
$-3.51M
1주 성능:
-3.91%
1개월 성능:
+4.70%
6개월 성능:
+27.61%
1년 성능:
-3.28%
1일 변동 폭
$35.08
$36.60
1주일 범위
$35.00
$37.36
52주 변동 폭
$26.00
$40.75
Sanara Medtech Inc Stock (SMTI) Company Profile
명칭
Sanara Medtech Inc
전화
817-529-2300
주소
1200 SUMMIT AVE, FORT WORTH
SMTI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
35.40 | 309.44M | 64.99M | -4.30M | -3.51M | -0.52 |
|
ISRG
Intuitive Surgical Inc
|
588.50 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.21 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
91.65 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
237.18 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
330.47 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-23 | 개시 | H.C. Wainwright | Buy |
| 2022-05-20 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-06-30 | 개시 | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc 주식(SMTI)의 최신 뉴스
Fifth Third Bancorp Makes New Investment in Sanara MedTech Inc. (NASDAQ:SMTI) - MarketBeat
JPMorgan Chase & Co. Boosts Stake in Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
Sanara MedTech expects Q4 revenue in the range of $25.7M to $26.2M - MSN
Sanara MedTech: A Promising Growth Story At An Attractive Valuation - Seeking Alpha
(SMTI) Investment Report - Stock Traders Daily
Cantor Fitzgerald Estimates Sanara MedTech FY2024 Earnings - Defense World
FY2024 EPS Estimate for Sanara MedTech Increased by Analyst - Defense World
FY2024 EPS Estimates for Sanara MedTech Increased by Analyst - MarketBeat
HC Wainwright Forecasts Stronger Earnings for Sanara MedTech - MarketBeat
Sanara MedTech’s (SMTI) Buy Rating Reiterated at HC Wainwright - Defense World
Sanara MedTech Inc. Announces the Commercial Launch of Two New Innovative Extracellular Matrix Products from Cook Biotech Inc. - ACCESS Newswire
Sanara MedTech Inc. Announces the Execution of a New License Agreement with Rochal Industries, LLC - ACCESS Newswire
Financial Comparison: Sanara MedTech (NASDAQ:SMTI) vs. ReWalk Robotics (NASDAQ:LFWD) - Defense World
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc. - The Manila Times
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, - GlobeNewswire
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution… - Informazione.it
Cantor Fitzgerald Comments on Sanara MedTech FY2025 Earnings - Defense World
Cantor Fitzgerald Estimates Sanara MedTech FY2025 Earnings - MarketBeat
HC Wainwright Reaffirms "Buy" Rating for Sanara MedTech (NASDAQ:SMTI) - MarketBeat
Insiders were the key beneficiaries as Sanara MedTech Inc.'s (NASDAQ:SMTI) market cap rises to US$297m - Simply Wall St
Sanara MedTech expands executive leadership team - Medical Buyer
Barclays PLC Has $174,000 Position in Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
Sanara MedTech Inc. Posts Strong Growth in Q4 and Full Year 2024 Results - Defense World
Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with Biomimetic Innovations Ltd - Defense World
Sanara MedTech Strengthens Leadership with New CFO Appointment - TipRanks
Sanara MedTech Secures U.S. Rights for OsStic - TipRanks
Cantor Fitzgerald lifts Sanara MedTech target to $46, retains Overweight By Investing.com - Investing.com South Africa
Cantor Fitzgerald lifts Sanara MedTech target to $46, retains Overweight - Investing.com
Cantor Fitzgerald Reiterates Overweight Rating for Sanara MedTech (NASDAQ:SMTI) - MarketBeat
Sanara MedTech expects Q4 revenue to increase 45%- 48% - Medical Buyer
SMTISanara MedTech Inc. Latest Stock News & Market Updates - StockTitan
Sanara MedTech reshapes executive team with new CFO and CAO - MSN
Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024 - The Manila Times
Sanara MedTech reshapes executive team with new CFO and CAO By Investing.com - Investing.com Canada
Sanara MedTech Inc. Announces Exclusive License and - GlobeNewswire
Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments - GlobeNewswire
Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd - Marketscreener.com
Sanara MedTech Inc. Announces the Execution of an Exclusive License and Distribution Agreement with Biomimetic Innovations Ltd - Marketscreener.com
Sanara MedTech Inc. Appoints Michael McNeil as Chief Accounting Officer and Chief Administrative Officer - Marketscreener.com
Sanara MedTech Reports Record Q4: Revenue Surges 48% on Strong Surgical Product Sales - StockTitan
How to Take Advantage of moves in (SMTI) - Stock Traders Daily
Barclays PLC Acquires 4,376 Shares of Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
Geode Capital Management LLC Grows Position in Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
How the (SMTI) price action is used to our Advantage - Stock Traders Daily
Sanara MedTech Inc. (NASDAQ:SMTI) Stake Boosted by State Street Corp - Defense World
HC Wainwright Comments on Sanara MedTech FY2024 Earnings - Defense World
Analysts Issue Forecasts for Sanara MedTech FY2024 Earnings - MarketBeat
H.C. Wainwright gives Sanara MedTech a Buy rating as market penetration strategy pays off - Investing.com Nigeria
Sanara MedTech (NASDAQ:SMTI) Now Covered by Analysts at HC Wainwright - Defense World
H.C. Wainwright gives Sanara MedTech a Buy rating as market penetration strategy pays off By Investing.com - Investing.com South Africa
HC Wainwright & Co. Initiates Coverage of Sanara MedTech (SMTI) with Buy Recommendation - MSN
Sanara Medtech Inc (SMTI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10.10%
0.93%
자본화:
|
볼륨(24시간):